SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Repayments of Related Party Debt
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Repayments of Related Party Debt of $190.27 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2026-09-24
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for the quarter ending 2025-06-30 was $63.40K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for the quarter ending 2025-03-31 was $61.54K.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for the quarter ending 2023-12-31 was $0.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for the quarter ending 2023-09-30 was $0.00.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for fiscal 2025 was $190.27K, a 218.55% increase from fiscal 2024.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for fiscal 2024 was $59.73K, a 91.29% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for fiscal 2023 was $685.47K, a 1270.95% increase from fiscal 2022.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. repayments of related party debt for fiscal 2022 was $50.00K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|---|
| 2025-12-31 | $190.27K 10-K · filed 2026-03-31 | |||
| 2025-06-30 | $63.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-09-24 | $124.94K 10-Q · filed 2026-09-24 | ||
| 2025-03-31 | $61.54K 10-Q · filed 2026-05-15 | |||
| 2024-12-31 | $59.73K 10-K · filed 2026-03-31 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $139.23K derived: sum of 3 quarters · filed 2025-02-26 | $685.47K 10-K · filed 2025-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $139.23K derived: sum of 2 quarters · filed 2024-11-13 | $685.47K 10-Q · filed 2024-11-13 | $685.47K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $139.23K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-09-04 | $685.47K 10-Q · filed 2024-09-04 | $685.47K derived: sum of 3 quarters · filed 2024-09-04 | |
| 2023-03-31 | $546.24K 10-Q/A · filed 2024-09-04 | $546.24K derived: sum of 2 quarters · filed 2024-09-04 | ||
| 2022-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-04 | $50.00K 10-K/A · filed 2024-09-04 | ||
| 2022-09-30 | $50.00K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |